TRDA
Price
$10.60
Change
+$0.53 (+5.26%)
Updated
Feb 6 closing price
Capitalization
405.12M
37 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$2.39
Change
+$0.18 (+8.14%)
Updated
Feb 6 closing price
Capitalization
154.75M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TRDA vs ZNTL

Header iconTRDA vs ZNTL Comparison
Open Charts TRDA vs ZNTLBanner chart's image
Entrada Therapeutics
Price$10.60
Change+$0.53 (+5.26%)
Volume$192.21K
Capitalization405.12M
Zentalis Pharmaceuticals
Price$2.39
Change+$0.18 (+8.14%)
Volume$841.94K
Capitalization154.75M
TRDA vs ZNTL Comparison Chart in %
TRDA
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TRDA vs. ZNTL commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (TRDA: $10.60 vs. ZNTL: $2.39)
Brand notoriety: TRDA and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 89% vs. ZNTL: 52%
Market capitalization -- TRDA: $403.98M vs. ZNTL: $154.75M
TRDA [@Biotechnology] is valued at $403.98M. ZNTL’s [@Biotechnology] market capitalization is $154.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 0 green, 5 red.
According to our system of comparison, both TRDA and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • TRDA’s TA Score: 3 bullish, 5 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than TRDA.

Price Growth

TRDA (@Biotechnology) experienced а -7.34% price change this week, while ZNTL (@Biotechnology) price change was -1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

TRDA is expected to report earnings on Mar 18, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($405M) has a higher market cap than ZNTL($155M). ZNTL YTD gains are higher at: 77.037 vs. TRDA (3.113). TRDA has higher annual earnings (EBITDA): -117.36M vs. ZNTL (-152.83M). TRDA has more cash in the bank: 327M vs. ZNTL (281M). ZNTL has less debt than TRDA: ZNTL (36.7M) vs TRDA (52.4M). TRDA has higher revenues than ZNTL: TRDA (61.5M) vs ZNTL (26.9M).
TRDAZNTLTRDA / ZNTL
Capitalization405M155M261%
EBITDA-117.36M-152.83M77%
Gain YTD3.11377.0374%
P/E Ratio10.26N/A-
Revenue61.5M26.9M229%
Total Cash327M281M116%
Total Debt52.4M36.7M143%
FUNDAMENTALS RATINGS
ZNTL: Fundamental Ratings
ZNTL
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRDAZNTL
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
TRDA
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BWOSF5.393.45
+177.18%
BW Offshore
CLGCF0.060.01
+27.39%
Clarity Metals Corp.
ALPMF14.90N/A
N/A
Astellas Pharma, Inc.
YKLTF15.45N/A
N/A
Yakult Honsha Co., Ltd.
CDIXD5.05-0.40
-7.34%
Cardiff Lexington Corporation

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with CGEM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+5.26%
CGEM - TRDA
75%
Closely correlated
+3.21%
IPSC - TRDA
75%
Closely correlated
+1.80%
TERN - TRDA
74%
Closely correlated
+6.88%
STRO - TRDA
73%
Closely correlated
+6.30%
ATOS - TRDA
72%
Closely correlated
+0.19%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+8.14%
IMVT - ZNTL
59%
Loosely correlated
+12.43%
IMNM - ZNTL
58%
Loosely correlated
+3.67%
TRDA - ZNTL
58%
Loosely correlated
+5.26%
SYRE - ZNTL
57%
Loosely correlated
+6.62%
IPSC - ZNTL
56%
Loosely correlated
+1.80%
More